11
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Phase II Trial of Ifosfamide in the Treatment of Metastatic Hormone-Refractory Patients with Prostatic Cancer

, , , &
Pages 477-481 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Primo N. Lara & Frederick J. Meyers. (1999) Treatment Options in Androgen-Independent Prostate Cancer. Cancer Investigation 17:2, pages 137-144.
Read now

Articles from other publishers (7)

Hong Zhang, Xia Du, Ting-Ting Sun, Chun-Liu Wang, Ye Li & Shou-Zhen Wu. (2017) Lectin PCL inhibits the Warburg effect of PC3 cells by combining with EGFR and inhibiting HK2. Oncology Reports.
Crossref
Dan J. Lewinshtein, Kian Tai Chong & John M. Corman. 2013. Urological Emergencies. Urological Emergencies 181 193 .
Tomasz Beer & Derek Raghavan. (2000) Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder. The Prostate 45:2, pages 184-193.
Crossref
D. Raghavan, B. Koczwara & M. Javle. (1997) Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. European Journal of Cancer 33:4, pages 566-574.
Crossref
Sridhar Mani & Nicholas J. Vogelzang. (1996) IS "OFF-PROTOCOL" CHEMOTHERAPY FOR ANDROGEN-INDEPENDENT CARCINOMA OF PROSTATE WARRANTED. Hematology/Oncology Clinics of North America 10:3, pages 749-768.
Crossref
Wen-Son Hsieh & Jonathan W. Simons. (1993) Systemic therapy of prostate cancer. new concepts from prostate cancer tumor biology. Cancer Treatment Reviews 19:3, pages 229-260.
Crossref
Andrew Canada, Linda Herman, Katherine Kidd, Cary Robertson & Donald Trump. (1993) Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line. Cancer Chemotherapy and Pharmacology 32:1, pages 73-77.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.